Click Therapeutics Deal History & Licensing Activity
Click Therapeutics is a life sciences. Over the past three years, Click Therapeutics has been involved in 1 licensing and acquisition transaction, with a primary focus on Other (2 deals).
Deals (12mo)
1
Active Trials
0
Top Modality
Other
Focus Area
Neurology
Click Therapeutics Recent Deal Activity
Licensing, acquisition, and partnership transactions involving Click Therapeutics in the past 12 months.
| Asset | Partner | Modality | Phase | Type | Date |
|---|---|---|---|---|---|
| CT-155 | Boehringer Ingelheim | Other | Phase 3 | license | Apr 2026 |
Click Therapeutics Pipeline Focus
Therapeutic areas and modalities where Click Therapeutics is most active based on deal history and clinical trial data.
See How Your Asset Matches Click Therapeutics's Portfolio
Use our deal calculator to benchmark upfront payments, milestones, and royalties for Neurology assets — powered by data from 3,500+ real biopharma transactions.
Related Intelligence
Neurology Deal Benchmarks
Market sizing, deal terms, and competitive landscape for neurology
Other Benchmarks
Upfront, milestone, and royalty benchmarks for other deals
Deal Pulse
Track the latest biopharma licensing and acquisition deals across all therapeutic areas
All Company Profiles
Browse 850+ biotech and pharma company profiles with deal history and pipeline data
2026 Deal Benchmarks Report
Industry-wide analysis of deal terms, trends, and market dynamics
About Click Therapeutics Licensing & Deal Activity
Click Therapeutics is a life sciences company that has been actively engaged in licensing transactions across the biopharma landscape. With 1 deal over the past three years, Click Therapeutics ranks among the actively acquisitive companies tracked by Ambrosia Ventures.
Key therapeutic areas of focus for Click Therapeutics include Neurology (2 deals and trials). In terms of modality, Click Therapeutics has shown particular interest in other.
Ambrosia Ventures tracks deal terms, pipeline data, patent expirations, and competitive positioning for Click Therapeutics and 850+ other biopharma companies. Use our deal calculator to benchmark your asset against Click Therapeutics's historical deal terms, or explore all company profiles to find the best partner match for your pipeline.